Platinum Investment Management LTD Has Boosted Five Prime Therapeutics (FPRX) Position; Shareholder Segall Bryant & Hamill Has Upped Pepsico (PEP) Holding

PepsiCo, Inc. (NASDAQ:PEP) Logo

Segall Bryant & Hamill Llc increased its stake in Pepsico Inc (PEP) by 5.33% based on its latest 2018Q1 regulatory filing with the SEC. Segall Bryant & Hamill Llc bought 13,868 shares as the company’s stock declined 9.58% with the market. The hedge fund held 273,822 shares of the consumer non-durables company at the end of 2018Q1, valued at $29.89 million, up from 259,954 at the end of the previous reported quarter. Segall Bryant & Hamill Llc who had been investing in Pepsico Inc for a number of months, seems to be bullish on the $144.38B market cap company. The stock increased 0.72% or $0.73 during the last trading session, reaching $101.83. About 4.83 million shares traded. PepsiCo, Inc. (NYSE:PEP) has declined 14.65% since May 31, 2017 and is downtrending. It has underperformed by 27.22% the S&P500.

Kerr Neilson increased its stake in Five Prime Therapeutics Inc (FPRX) by 50% based on its latest 2018Q1 regulatory filing with the SEC. Platinum Investment Management Ltd bought 31,400 shares as the company’s stock declined 1.07% with the market. The hedge fund run by Kerr Neilson held 94,200 shares of the health care company at the end of 2018Q1, valued at $1.62 million, up from 62,800 at the end of the previous reported quarter. Platinum Investment Management Ltd who had been investing in Five Prime Therapeutics Inc for a number of months, seems to be bullish on the $634.47 million market cap company. The stock decreased 0.61% or $0.11 during the last trading session, reaching $18.02. About 298,819 shares traded. Five Prime Therapeutics, Inc. (NASDAQ:FPRX) has declined 37.93% since May 31, 2017 and is downtrending. It has underperformed by 50.50% the S&P500.

Investors sentiment is 0.86 in 2018 Q1. Its the same as in 2017Q4. It has no change, as 67 investors sold PEP shares while 715 reduced holdings. only 119 funds opened positions while 550 raised stakes. 956.07 million shares or 0.28% less from 958.76 million shares in 2017Q4 were reported. Rfg Advisory Group Inc Ltd Llc holds 0.11% or 2,714 shares in its portfolio. Chatham Group Incorporated holds 0.78% in PepsiCo, Inc. (NASDAQ:PEP) or 26,441 shares. First Citizens Natl Bank And Tru reported 52,017 shares or 0.77% of all its holdings. Moreover, Eagleclaw Cap Managment Lc has 0.4% invested in PepsiCo, Inc. (NASDAQ:PEP). Boston Rech And Mngmt Inc holds 1.9% in PepsiCo, Inc. (NASDAQ:PEP) or 34,253 shares. Bsw Wealth Partners stated it has 5,325 shares or 0.26% of all its holdings. 423,151 are held by Williams Jones & Assoc. Bartlett Co Llc holds 473,766 shares or 2.14% of its portfolio. First Mercantile Tru Com holds 0.44% of its portfolio in PepsiCo, Inc. (NASDAQ:PEP) for 19,352 shares. 44,954 were accumulated by Princeton Port Strategies Gp Ltd Co. New England Private Wealth Advsr Limited Liability stated it has 0.11% in PepsiCo, Inc. (NASDAQ:PEP). Baldwin Mgmt Lc reported 0.1% in PepsiCo, Inc. (NASDAQ:PEP). Jp Marvel Investment Ltd Liability holds 0.1% of its portfolio in PepsiCo, Inc. (NASDAQ:PEP) for 2,971 shares. Calamos Limited Liability Corp has invested 0.4% of its portfolio in PepsiCo, Inc. (NASDAQ:PEP). Tradition Capital Management Limited has 12,151 shares.

Segall Bryant & Hamill Llc, which manages about $9.47 billion and $4.32B US Long portfolio, decreased its stake in Callon Petroleum Co (NYSE:CPE) by 28,509 shares to 457,349 shares, valued at $6.06M in 2018Q1, according to the filing. It also reduced its holding in Icu Medical Inc (NASDAQ:ICUI) by 10,749 shares in the quarter, leaving it with 86,347 shares, and cut its stake in Raytheon Company (NYSE:RTN).

More news for PepsiCo, Inc. (NASDAQ:PEP) were recently published by: Bizjournals.com, which released: “PepsiCo buys SF-based Bare Foods as food giants shop Bay Area for innovation” on May 25, 2018. Livetradingnews.com‘s article titled: “PepsiCo, Inc. (NASDAQ:PEP) Heffx Trading Review” and published on May 29, 2018 is yet another important article.

Among 22 analysts covering PepsiCo (NYSE:PEP), 8 have Buy rating, 1 Sell and 13 Hold. Therefore 36% are positive. PepsiCo had 69 analyst reports since July 21, 2015 according to SRatingsIntel. The stock of PepsiCo, Inc. (NASDAQ:PEP) has “Outperform” rating given on Friday, September 16 by Credit Suisse. Jefferies maintained the shares of PEP in report on Friday, September 30 with “Buy” rating. The firm earned “Buy” rating on Monday, January 8 by Cowen & Co. BMO Capital Markets downgraded PepsiCo, Inc. (NASDAQ:PEP) on Wednesday, June 7 to “Market Perform” rating. The firm has “Hold” rating given on Monday, October 2 by Jefferies. On Thursday, August 27 the stock rating was downgraded by Vetr to “Buy”. On Monday, February 12 the stock rating was maintained by Susquehanna with “Buy”. The firm has “Sector Perform” rating by RBC Capital Markets given on Wednesday, October 7. The rating was maintained by Barclays Capital on Tuesday, April 19 with “Overweight”. The firm earned “Neutral” rating on Monday, November 23 by Nomura.

Investors sentiment increased to 2.33 in 2018 Q1. Its up 0.99, from 1.34 in 2017Q4. It improved, as 21 investors sold FPRX shares while 12 reduced holdings. 21 funds opened positions while 56 raised stakes. 31.62 million shares or 24.14% more from 25.47 million shares in 2017Q4 were reported. United Cap Advisers Ltd Liability has 12,610 shares for 0% of their portfolio. Prelude Mngmt Limited Liability Corp has 0% invested in Five Prime Therapeutics, Inc. (NASDAQ:FPRX). Virginia Retirement Sys Et Al accumulated 34,900 shares. Swiss National Bank invested in 0% or 59,400 shares. Glenmede Commerce Na has invested 0% in Five Prime Therapeutics, Inc. (NASDAQ:FPRX). Cubist Systematic Strategies stated it has 11,163 shares or 0.01% of all its holdings. Schwab Charles Invest Mngmt Inc holds 153,323 shares or 0% of its portfolio. Rhumbline Advisers accumulated 32,367 shares or 0% of the stock. Citigroup holds 0% in Five Prime Therapeutics, Inc. (NASDAQ:FPRX) or 21,053 shares. Art owns 158,769 shares or 0.11% of their US portfolio. The New York-based Quantbot Technologies Lp has invested 0.01% in Five Prime Therapeutics, Inc. (NASDAQ:FPRX). Hudson Bay Cap Management Limited Partnership accumulated 100,000 shares or 0.04% of the stock. Great West Life Assurance Company Can reported 4,651 shares or 0% of all its holdings. Bogle Investment Management LP De invested 0.09% in Five Prime Therapeutics, Inc. (NASDAQ:FPRX). Winslow Evans Crocker holds 0% of its portfolio in Five Prime Therapeutics, Inc. (NASDAQ:FPRX) for 20 shares.

More notable recent Five Prime Therapeutics, Inc. (NASDAQ:FPRX) news were published by: Seekingalpha.com which released: “Five Prime Therapeutics’ (FPRX) CEO Aron Knickerbocker on Q1 2018 Results – Earnings Call Transcript” on May 13, 2018, also Businesswire.com with their article: “Five Prime Therapeutics Announces Collaboration with Roche to Develop Companion Diagnostics for Targeted …” published on May 30, 2018, Bizjournals.com published: “Why this Peninsula startup is primed for an $80.5 million IPO” on May 24, 2018. More interesting news about Five Prime Therapeutics, Inc. (NASDAQ:FPRX) were released by: Bizjournals.com and their article: “Why Big Pharma is finally discovering the Bay Area” published on May 23, 2018 as well as Streetinsider.com‘s news article titled: “Five Prime Therapeutics (FPRX) Announces Pact with Roche to Develop Companion Diagnostics for Targeted Immuno …” with publication date: May 30, 2018.

Five Prime Therapeutics, Inc. (NASDAQ:FPRX) Institutional Positions Chart